These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 7879005
1. Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1995 Feb; 27(1):286-7. PubMed ID: 7879005 [No Abstract] [Full Text] [Related]
2. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012 [No Abstract] [Full Text] [Related]
3. Rejection of cardiac xenografts by CD4+ or CD8+ T cells. Lin Y, Soares MP, Sato K, Takigami K, Csizmadia E, Anrather J, Bach FH. J Immunol; 1999 Jan 15; 162(2):1206-14. PubMed ID: 9916754 [Abstract] [Full Text] [Related]
5. Complement- and xenoantibody-independent discordant xenograft rejection in a guinea pig to rat model. Ji P, Xia GL, Waer M. Transplant Proc; 2000 Aug 15; 32(5):935. PubMed ID: 10936281 [No Abstract] [Full Text] [Related]
7. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats. Lin Y, Vandeputte M, Waer M. Transplant Proc; 1996 Apr 15; 28(2):741. PubMed ID: 8623376 [No Abstract] [Full Text] [Related]
8. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation. Yasutomi M, Hayashi S, Ohtsuka S, Namii Y, Ito M, Uchida K, Yokoyama I, Takagi H. Transplant Proc; 1995 Apr 15; 27(2):1583-4. PubMed ID: 7725417 [No Abstract] [Full Text] [Related]
10. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1994 Dec 15; 26(6):3202. PubMed ID: 7998115 [No Abstract] [Full Text] [Related]
11. Mechanisms of protection from humoral rejection by a xenografted liver. Celli S, Valdivia LA, Kelly RH, Sun H, Tsugita M, Pan F, Rao AS, Demetris AJ, Fung JJ, Starzl TE. Transplant Proc; 1995 Feb 15; 27(1):300-2. PubMed ID: 7533395 [No Abstract] [Full Text] [Related]
12. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. Lin Y, Vandeputte M, Waer M. J Immunol; 1997 Jun 15; 158(12):5658-67. PubMed ID: 9190914 [Abstract] [Full Text] [Related]
15. Prolongation of hamster-to-rat cardiac xenograft survival by hyperimmune blood transfusion without immunosuppression. Lee PC, Lei HY, Hung CJ, Arakawa K, Oka T. Transplant Proc; 1996 Jun 15; 28(3):1397-9. PubMed ID: 8658711 [No Abstract] [Full Text] [Related]
18. A new flowcytometric CDC assay for detection of cytotoxic antibodies applied to hamster-to-rat cardiac transplantation. Lillevang ST, Steinbrüchel DA, Kristensen T, Kemp E. Transplant Proc; 1992 Apr 15; 24(2):537-8. PubMed ID: 1566421 [No Abstract] [Full Text] [Related]
19. Establishment of a concordant xenogeneic splenocyte injection model for the dynamic study of the marginal zone in the spleen. Yasutomi M, Ito M, Hayashi S, Ohtsuka S, Namii Y, Uchida K, Yokoyama I, Takagi H. J Heart Lung Transplant; 1998 May 15; 17(5):452-9. PubMed ID: 9628563 [Abstract] [Full Text] [Related]
20. Prolongation of heart xenograft survival in the NK-deficient rat. Arakawa K, Akami T, Okamoto M, Akioka K, Lee PC, Sugano Y, Kamei J, Suzuki T, Nagase H, Tsuchihashi Y. Transplant Proc; 1994 Jun 15; 26(3):1266-7. PubMed ID: 8029903 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]